Developer docs
API playgroundTry for free, no card

Search company profiles

Cleveland Clinic Abu Dhabi

Full company profile

uuid00039nl

Namestring
Cleveland Clinic Abu Dhabi
Legal namestring
Cleveland Clinic Abu Dhabi LLC
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Cleveland Clinic Abu Dhabi is a 364-bed (expandable to 490) multispecialty tertiary and quaternary hospital on Al Maryah Island in Abu Dhabi, operating as part of the M42 group under a joint venture between Mubadala Investment Company and Cleveland Clinic (US), established through a 2006 agreement and opened in 2015. The hospital delivers care across 50+ medical and surgical specialties organized into eight institutes (Cancer/Fatima bint Mubarak Center, Diagnostics, Digestive Disease, Heart Vascular & Thoracic, Neurological, Integrated Surgical, Medical Specialty, and Integrated Hospital Care), supplemented by the Executive Health Program and UAE's first and only multi-organ transplant center, with 800+ transplants performed in under a decade and nearly 10,000 complex procedures in 2025.

The underlying technology stack includes AI-powered clinical decision support (Aila, co-developed with Owkin as the world's first clinical AI scientist using natural language processing across EHRs, pathology, imaging, and physician notes), computer vision-based diagnostics (Qritive for prostate cancer pathology, FLAIRstar for multiple sclerosis MRI), an AI-driven surgical intelligence network (Johnson & Johnson's Polyphonic with AWS and NVIDIA), robotic-assisted surgical systems for minimally invasive procedures including lung transplants and remote kidney telesurgery, and AI-powered multi-cancer early detection with genomic sequencing for biomarker-driven therapy.

Revenue is generated through patient care services billed via direct pay, insurance partnerships (Aafiya, Adnic, Aetna, Axa, Daman, Damana, among others), and corporate channels. Go-to-market combines direct-to-consumer medical tourism (35% international patient volume growth in 2024 across Kuwait, Saudi Arabia, Pakistan, Bahrain, and USA), exclusive digital distribution partnerships (DAWI in Kuwait for Executive Health Program), professional referrals, and government/ecosystem partnerships with the Department of Health Abu Dhabi. Strategic positioning emphasizes serving patients across the GCC and wider region who would otherwise travel abroad for complex care, supported by JCI, Magnet, ACCME, and CAP accreditations and five consecutive years as the top-ranked Smart Hospital in the UAE and GCC by Newsweek.

Short descriptiontext

Cleveland Clinic Abu Dhabi is a 364-bed tertiary and quaternary multispecialty hospital on Al Maryah Island, serving UAE residents and international medical tourists from across the GCC, South Asia, and beyond with complex procedures, transplants, oncology, and AI-augmented diagnostics as part of the M42 group under a Mubadala-Cleveland Clinic joint venture.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersAbu Dhabi, United Arab Emirates
HQ citystring
Abu Dhabi
HQ countrystring
United Arab Emirates
HQ regionstring
Middle East
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
multispecialty hospital services, tertiary healthcare services, quaternary medical care, clinical institutes, transplant services
Industry1 code
1Hospital-Integrated Cancer Centers (Acute Oncology Programs)
CodeHLAFAAAMPrimaryYes
NAICS code1 code
  • General Medical and Surgical Hospitals62211
SIC code1 code
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
Multispecialty Hospital Services
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model4 records
1Patient Care Services
TypeProfessional Services
Description

Tertiary and quaternary healthcare services including complex surgical procedures, transplants, cancer care, and executive health programs. Revenue generated through direct patient billing, insurance claims, and self-pay arrangements.

gulfnews.com
2International Patient Services
TypeProfessional Services
Description

Cross-border healthcare services attracting medical tourists with 35% growth in international patient volume. Services include comprehensive diagnostic workups, treatment programs, and concierge support for international patients.

gulfnews.com
3Executive Health Program
TypeProfessional Services
Description

Comprehensive health check-up programs and preventive medicine services for individuals and corporate clients, including partnership with DAWI for Kuwaiti market access.

healthcareasiamagazine.com
4Clinical Trials and Research
TypeProfessional Services
Description

Research and innovation activities including clinical trials conducted in partnership with global pharmaceutical and biotech companies, supported by Department of Health funding.

clevelandclinicabudhabi.ae
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels7 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain
Pricing details2 tiers
1Comprehensive Health Check-up
ModelOtherBilling cadenceMulti-year contract
Notes

Executive Health Program services include comprehensive health screening packages with pricing determined upon consultation and assessment of individual needs.

clevelandclinicabudhabi.ae
2Self-Pay and Insurance Billing
ModelOtherBilling cadencePay-as-you-go
Notes

Self-pay services available with pricing based on procedure complexity. Insurance partnerships with major providers including Aafiya, Adnic, Aetna, Axa, Daman, and Damana.

clevelandclinicabudhabi.ae
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Cleveland Clinic Abu Dhabi is a multispecialty tertiary and quaternary hospital on Al Maryah Island, Abu Dhabi, providing advanced medical and surgical care across multiple clinical institutes, including cancer, cardiac, neurological, digestive disease, and integrated surgical services. The hospital performs complex procedures such as organ transplantation, robotic surgery, and AI-assisted diagnostics, and functions as a regional referral center serving patients in the UAE and the wider Middle East.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 7 values shown
  • 35% growth in international patient volume with over 10,000 international patient encounters
+6 more records
Product overview1 text field

Cleveland Clinic Abu Dhabi is a 411-bed multispecialty hospital on Al Maryah Island in Abu Dhabi, offering care across 50+ medical and surgical specialties through 8 dedicated institutes. The hospital operates a platform-plus-specialty model with its core institutes (Cancer Institute/Fatima bint Mubarak Center, Diagnostics Institute, Digestive Disease Institute, Heart & Thoracic Institute, Neurological Institute, Integrated Surgical Institute, Medical Specialty Institute, and Integrated Hospital Care Institute) providing comprehensive care, supplemented by specialized programs including the Executive Health Program, Abdominal Transplant Program, and Multidisciplinary Simulation Center. Recent innovations include the Aila clinical AI scientist platform and AI-powered prostate cancer diagnostics through the Diagnostics Institute.

Product and service1 record
1Cancer Institute (Fatima bint Mubarak Center)
Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-17
Description

Collaboration to launch 'Aila,' the world's first clinical AI scientist, designed to support real-time clinical decision-making and accelerate medical research using real patient data. The AI platform uses natural language processing to query vast amounts of clinical data and deliver insights that previously required days or weeks of manual analysis. Initial deployment focuses on prostate cancer, with plans to scale across additional medical specialities.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-06-12
Description

Joint research with NYU Abu Dhabi to develop injectable wireless medical device capable of controlling nerve activity without surgery, batteries, or wires. The device, roughly the size of a small seed, can be injected near a target nerve and delivers programmable electrical stimulation powered wirelessly, allowing real-time adjustment.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-06-09
Description

Partnership between M42's National Reference Laboratory and Qritive to introduce AI-powered prostate cancer diagnostics in the UAE, integrated into Cleveland Clinic Abu Dhabi's diagnostic workflow. The platform analyzes digital pathology slides to help detect prostate cancer, assess tumor patterns, and support grading according to internationally recognised standards.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-21
Description

Collaboration with Department of Health Abu Dhabi to launch global surgical intelligence network using Johnson & Johnson's Polyphonic digital ecosystem. The initiative integrates technology partners AWS and NVIDIA to deploy AI-powered surgical tools across operating rooms, connecting hospitals including Cleveland Clinic Abu Dhabi to capture surgical video and multimodal data for AI development. Abu Dhabi serves as first node in worldwide infrastructure for AI-driven surgical innovation.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-19
Description

Oversees clinical operations for UAE's first clinical trial for gene therapy targeting MerTK-related retinitis pigmentosa. The trial, developed by Opus Genetics, is funded by Authority of Social Contribution Ma'an with clinical development activities expected to commence in 2026.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2026-01-27
Description

Clinical trial evaluating OPGx-MERTK gene therapy for MERTK-related retinitis pigmentosa conducted at Cleveland Clinic Abu Dhabi. Trial funded through Abu Dhabi's Healthcare Research and Innovation Fund, supported by Department of Health Abu Dhabi, M42's IROS division, and Authority of Social Contribution Ma'an. Positions Abu Dhabi as hub for precision medicine.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2026-01-14
Description

DAWI serves as exclusive digital partner for Cleveland Clinic Abu Dhabi's Executive Health Program in the Kuwaiti market. The partnership enables users in Kuwait to search, book, and manage executive health services delivered in Abu Dhabi through a digital platform. Later phases may extend to additional medical specialties and services.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Licensing and regulatory partnership as designated research and teaching facility. Department of Health supports clinical trials and innovation initiatives including intelligent surgical network and gene therapy trials. Also provides designations as Teaching Hospital, Official Stroke Center, and Centre of Excellence for Adult Cardiac Surgery.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-10-08
Description

Partnership to develop UAE's first hospital-based vertiport for electric air taxi access using Archer's Midnight eVTOL aircraft. The vertiport would serve both non-emergency passenger transport and time-critical organ transport, with upgrade of existing helipad infrastructure to enable both traditional helicopter and eVTOL operations.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-09-18
Description

Collaboration to develop FLAIRstar, an AI-powered MRI analysis technique for Multiple Sclerosis diagnosis. The tool automatically detects the central vein sign in brain lesions using LAMINATE project methodology supported by National MS Society. All patient data secured within UAE.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2015-01-01
Description

Cleveland Clinic Abu Dhabi is extension of Cleveland Clinic model of care, providing access to world-class clinical practices, research methodologies, and global best practices. Modeled on Cleveland Clinic's Taussig Cancer Center and other renowned institutes.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Largest private hospital group in MENA region with multi-specialty tertiary hospitals. Competes for medical tourism across GCC and offers similar complex care capabilities in the region.

TypeRegional player
Description

Saudi Arabia's premier tertiary/quaternary hospital and research center. Competes for regional complex care patients across GCC, particularly for oncology, transplant, and genetic medicine cases.

TypeDirect peer
Description

Operates multi-specialty hospitals across UAE with similar premium positioning and international patient services. Directly competes with CCAD for medical tourism volume and complex care referrals in the region.

TypeDirect peer
Description

Largest private healthcare provider in UAE with multi-specialty hospitals serving similar patient demographics. Competes on complex care and is a participant in Abu Dhabi's intelligent surgical network.

TypeBroad incumbent
Description

Parent brand and operator providing clinical model, protocols, and physician expertise to CCAD. Comparable as a global multi-specialty academic medical center with similar specialty institutes and research orientation.

TypeDirect peer
Description

Multi-specialty hospital in Abu Dhabi operated as part of M42 network. Competes within same geography for complex care cases and participates in similar government partnerships.

TypeDirect peer
Description

International brand-affiliated multi-specialty hospital in UAE with similar positioning as a UK-branded tertiary care destination. Competes for international patients and complex case referrals.

TypeDirect peer
Description

UAE-based multi-specialty hospital group with premium positioning and complex care services. Direct competitor in Abu Dhabi and broader UAE market for tertiary/quaternary care.

TypeRegional player
Description

Qatar-based specialty hospital affiliated with Weill Cornell with similar premium positioning and complex care focus. Competes for GCC medical tourism market, particularly for women's and pediatric specialty services.

TypeDirect peer
Description

Multi-specialty tertiary hospital in UAE with US-affiliated physicians and similar premium/complex care positioning. Competes for international patients and complex cases across similar specialties.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability10 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance9 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cleveland Clinic Abu Dhabi

Multispecialty Hospital Servicesclevelandclinicabudhabi.ae

Cleveland Clinic Abu Dhabi is a 364-bed tertiary and quaternary multispecialty hospital on Al Maryah Island, serving UAE residents and international medical tourists from across the GCC, South Asia, and beyond with complex procedures, transplants, oncology, and AI-augmented diagnostics as part of the M42 group under a Mubadala-Cleveland Clinic joint venture.

What Cleveland Clinic Abu Dhabi does

Cleveland Clinic Abu Dhabi is a 364-bed (expandable to 490) multispecialty tertiary and quaternary hospital on Al Maryah Island in Abu Dhabi, operating as part of the M42 group under a joint venture between Mubadala Investment Company and Cleveland Clinic (US), established through a 2006 agreement and opened in 2015. The hospital delivers care across 50+ medical and surgical specialties organized into eight institutes (Cancer/Fatima bint Mubarak Center, Diagnostics, Digestive Disease, Heart Vascular & Thoracic, Neurological, Integrated Surgical, Medical Specialty, and Integrated Hospital Care), supplemented by the Executive Health Program and UAE's first and only multi-organ transplant center, with 800+ transplants performed in under a decade and nearly 10,000 complex procedures in 2025.

The underlying technology stack includes AI-powered clinical decision support (Aila, co-developed with Owkin as the world's first clinical AI scientist using natural language processing across EHRs, pathology, imaging, and physician notes), computer vision-based diagnostics (Qritive for prostate cancer pathology, FLAIRstar for multiple sclerosis MRI), an AI-driven surgical intelligence network (Johnson & Johnson's Polyphonic with AWS and NVIDIA), robotic-assisted surgical systems for minimally invasive procedures including lung transplants and remote kidney telesurgery, and AI-powered multi-cancer early detection with genomic sequencing for biomarker-driven therapy.

Revenue is generated through patient care services billed via direct pay, insurance partnerships (Aafiya, Adnic, Aetna, Axa, Daman, Damana, among others), and corporate channels. Go-to-market combines direct-to-consumer medical tourism (35% international patient volume growth in 2024 across Kuwait, Saudi Arabia, Pakistan, Bahrain, and USA), exclusive digital distribution partnerships (DAWI in Kuwait for Executive Health Program), professional referrals, and government/ecosystem partnerships with the Department of Health Abu Dhabi. Strategic positioning emphasizes serving patients across the GCC and wider region who would otherwise travel abroad for complex care, supported by JCI, Magnet, ACCME, and CAP accreditations and five consecutive years as the top-ranked Smart Hospital in the UAE and GCC by Newsweek.

Cleveland Clinic Abu Dhabi firmographics

Firmographics
Name
Cleveland Clinic Abu Dhabi
Legal name
Cleveland Clinic Abu Dhabi LLC
Website
https://clevelandclinicabudhabi.ae
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Cleveland Clinic Abu Dhabi is a 364-bed tertiary and quaternary multispecialty hospital on Al Maryah Island, serving UAE residents and international medical tourists from across the GCC, South Asia, and beyond with complex procedures, transplants, oncology, and AI-augmented diagnostics as part of the M42 group under a Mubadala-Cleveland Clinic joint venture.
Ownership category
akta.pro rank

Cleveland Clinic Abu Dhabi industry classification

Industry
Product category
Multispecialty Hospital Services
NAICS
General Medical and Surgical Hospitals (62211)
SIC
Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

  • Multispecialty hospital services
  • Tertiary healthcare services
  • Quaternary medical care
  • Clinical institutes
  • Transplant services

Where Cleveland Clinic Abu Dhabi is headquartered

Location

Headquarters

HQ city
Abu Dhabi
HQ country
United Arab Emirates
HQ region
Middle East

Offices1 record

Markets served

Cleveland Clinic Abu Dhabi business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

  1. Patient Care Services: Tertiary and quaternary healthcare services including complex surgical procedures, transplants, cancer care, and executive health programs. Revenue generated through direct patient billing, insurance claims, and self-pay arrangements.
  2. International Patient Services: Cross-border healthcare services attracting medical tourists with 35% growth in international patient volume. Services include comprehensive diagnostic workups, treatment programs, and concierge support for international patients.
  3. Executive Health Program: Comprehensive health check-up programs and preventive medicine services for individuals and corporate clients, including partnership with DAWI for Kuwaiti market access.
  4. Clinical Trials and Research: Research and innovation activities including clinical trials conducted in partnership with global pharmaceutical and biotech companies, supported by Department of Health funding.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractComprehensive Health Check-up
OtherPay-as-you-goSelf-Pay and Insurance Billing

Go-to-market motion4 records

Distribution channels7 records

Marketing channels8 records

Cleveland Clinic Abu Dhabi product offering

Product offering

Core offering

Cleveland Clinic Abu Dhabi is a multispecialty tertiary and quaternary hospital on Al Maryah Island, Abu Dhabi, providing advanced medical and surgical care across multiple clinical institutes, including cancer, cardiac, neurological, digestive disease, and integrated surgical services. The hospital performs complex procedures such as organ transplantation, robotic surgery, and AI-assisted diagnostics, and functions as a regional referral center serving patients in the UAE and the wider Middle East.

Product overview

Cleveland Clinic Abu Dhabi is a 411-bed multispecialty hospital on Al Maryah Island in Abu Dhabi, offering care across 50+ medical and surgical specialties through 8 dedicated institutes. The hospital operates a platform-plus-specialty model with its core institutes (Cancer Institute/Fatima bint Mubarak Center, Diagnostics Institute, Digestive Disease Institute, Heart & Thoracic Institute, Neurological Institute, Integrated Surgical Institute, Medical Specialty Institute, and Integrated Hospital Care Institute) providing comprehensive care, supplemented by specialized programs including the Executive Health Program, Abdominal Transplant Program, and Multidisciplinary Simulation Center. Recent innovations include the Aila clinical AI scientist platform and AI-powered prostate cancer diagnostics through the Diagnostics Institute.

Differentiator

Problem solved

Functional benefit

Products and services

  • Cancer Institute (Fatima bint Mubarak Center)

Quantifiable outcome

  • 35% growth in international patient volume with over 10,000 international patient encounters
  • +6 more outcomes

Companies that use Cleveland Clinic Abu Dhabi

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles2 records

Cleveland Clinic Abu Dhabi technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability10 records

Feature9 records

Cleveland Clinic Abu Dhabi partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • OwkincoreStrategic or Co-development Partner · 17 June 2026Collaboration to launch 'Aila,' the world's first clinical AI scientist, designed to support real-time clinical decision-making and accelerate medical research using real patient data. The AI platform uses natural language processing to query vast amounts of clinical data and deliver insights that previously required days or weeks of manual analysis. Initial deployment focuses on prostate cancer, with plans to scale across additional medical specialities.
  • NYU Abu DhabiminorStrategic or Co-development Partner · 12 June 2026Joint research with NYU Abu Dhabi to develop injectable wireless medical device capable of controlling nerve activity without surgery, batteries, or wires. The device, roughly the size of a small seed, can be injected near a target nerve and delivers programmable electrical stimulation powered wirelessly, allowing real-time adjustment.
  • QritivecoreTechnology or Integration · 9 June 2026Partnership between M42's National Reference Laboratory and Qritive to introduce AI-powered prostate cancer diagnostics in the UAE, integrated into Cleveland Clinic Abu Dhabi's diagnostic workflow. The platform analyzes digital pathology slides to help detect prostate cancer, assess tumor patterns, and support grading according to internationally recognised standards.
  • Johnson & JohnsoncoreStrategic or Co-development Partner · 21 May 2026Collaboration with Department of Health Abu Dhabi to launch global surgical intelligence network using Johnson & Johnson's Polyphonic digital ecosystem. The initiative integrates technology partners AWS and NVIDIA to deploy AI-powered surgical tools across operating rooms, connecting hospitals including Cleveland Clinic Abu Dhabi to capture surgical video and multimodal data for AI development. Abu Dhabi serves as first node in worldwide infrastructure for AI-driven surgical innovation.
  • M42's IROS DivisioncoreStrategic or Co-development Partner · 19 May 2026Oversees clinical operations for UAE's first clinical trial for gene therapy targeting MerTK-related retinitis pigmentosa. The trial, developed by Opus Genetics, is funded by Authority of Social Contribution Ma'an with clinical development activities expected to commence in 2026.
  • Opus GeneticsminorStrategic or Co-development Partner · 27 January 2026Clinical trial evaluating OPGx-MERTK gene therapy for MERTK-related retinitis pigmentosa conducted at Cleveland Clinic Abu Dhabi. Trial funded through Abu Dhabi's Healthcare Research and Innovation Fund, supported by Department of Health Abu Dhabi, M42's IROS division, and Authority of Social Contribution Ma'an. Positions Abu Dhabi as hub for precision medicine.
  • DAWIcoreChannel Partner/ Reseller/ Distributor · 14 January 2026DAWI serves as exclusive digital partner for Cleveland Clinic Abu Dhabi's Executive Health Program in the Kuwaiti market. The partnership enables users in Kuwait to search, book, and manage executive health services delivered in Abu Dhabi through a digital platform. Later phases may extend to additional medical specialties and services.
  • Department of Health Abu DhabicoreStrategic or Co-development Partner · 1 January 2026Licensing and regulatory partnership as designated research and teaching facility. Department of Health supports clinical trials and innovation initiatives including intelligent surgical network and gene therapy trials. Also provides designations as Teaching Hospital, Official Stroke Center, and Centre of Excellence for Adult Cardiac Surgery.
  • Archer AviationminorStrategic or Co-development Partner · 8 October 2025Partnership to develop UAE's first hospital-based vertiport for electric air taxi access using Archer's Midnight eVTOL aircraft. The vertiport would serve both non-emergency passenger transport and time-critical organ transport, with upgrade of existing helipad infrastructure to enable both traditional helicopter and eVTOL operations.
  • NYU Abu Dhabi, Yas Clinic Khalifa City, Abu Dhabi Stem Cells CenterminorStrategic or Co-development Partner · 18 September 2025Collaboration to develop FLAIRstar, an AI-powered MRI analysis technique for Multiple Sclerosis diagnosis. The tool automatically detects the central vein sign in brain lesions using LAMINATE project methodology supported by National MS Society. All patient data secured within UAE.
  • Cleveland Clinic (US)coreStrategic or Co-development Partner · 1 January 2015Cleveland Clinic Abu Dhabi is extension of Cleveland Clinic model of care, providing access to world-class clinical practices, research methodologies, and global best practices. Modeled on Cleveland Clinic's Taussig Cancer Center and other renowned institutes.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Cleveland Clinic Abu Dhabi competitors and assessment

Company assessment

Direct peers

  • Saudi German Hospital Group: Largest private hospital group in MENA region with multi-specialty tertiary hospitals. Competes for medical tourism across GCC and offers similar complex care capabilities in the region.
  • Mediclinic Middle East: Operates multi-specialty hospitals across UAE with similar premium positioning and international patient services. Directly competes with CCAD for medical tourism volume and complex care referrals in the region.
  • NMC Healthcare: Largest private healthcare provider in UAE with multi-specialty hospitals serving similar patient demographics. Competes on complex care and is a participant in Abu Dhabi's intelligent surgical network.
  • Healthpoint Abu Dhabi: Multi-specialty hospital in Abu Dhabi operated as part of M42 network. Competes within same geography for complex care cases and participates in similar government partnerships.
  • King's College Hospital London (Dubai): International brand-affiliated multi-specialty hospital in UAE with similar positioning as a UK-branded tertiary care destination. Competes for international patients and complex case referrals.
  • Burjeel Hospital: UAE-based multi-specialty hospital group with premium positioning and complex care services. Direct competitor in Abu Dhabi and broader UAE market for tertiary/quaternary care.
  • American Hospital Dubai: Multi-specialty tertiary hospital in UAE with US-affiliated physicians and similar premium/complex care positioning. Competes for international patients and complex cases across similar specialties.

Regional players

  • King Faisal Specialist Hospital and Research Centre: Saudi Arabia's premier tertiary/quaternary hospital and research center. Competes for regional complex care patients across GCC, particularly for oncology, transplant, and genetic medicine cases.
  • Sidra Medicine: Qatar-based specialty hospital affiliated with Weill Cornell with similar premium positioning and complex care focus. Competes for GCC medical tourism market, particularly for women's and pediatric specialty services.

Broad incumbents

  • Cleveland Clinic (US): Parent brand and operator providing clinical model, protocols, and physician expertise to CCAD. Comparable as a global multi-specialty academic medical center with similar specialty institutes and research orientation.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Cleveland Clinic Abu Dhabi social profiles

Digital presence

Cleveland Clinic Abu Dhabi compliance and trust

Trust signal

Compliance9 records

Cleveland Clinic Abu Dhabi financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cleveland Clinic Abu Dhabi leadership team

Management profile

Number of profiles

Profiles2 records

Cleveland Clinic Abu Dhabi funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cleveland Clinic Abu Dhabi M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cleveland Clinic Abu Dhabi

What does Cleveland Clinic Abu Dhabi do?

Cleveland Clinic Abu Dhabi is a multispecialty tertiary and quaternary hospital on Al Maryah Island, Abu Dhabi, providing advanced medical and surgical care across multiple clinical institutes, including cancer, cardiac, neurological, digestive disease, and integrated surgical services. The hospital performs complex procedures such as organ transplantation, robotic surgery, and AI-assisted diagnostics, and functions as a regional referral center serving patients in the UAE and the wider Middle East.

Is Cleveland Clinic Abu Dhabi a public or private company?

Cleveland Clinic Abu Dhabi is a private company. It is classified as corporate owned and is currently operating.

When was Cleveland Clinic Abu Dhabi founded?

Cleveland Clinic Abu Dhabi was founded in 2015. It employs 1,001 to 5,000 people.

Where is Cleveland Clinic Abu Dhabi based?

Cleveland Clinic Abu Dhabi is headquartered in Abu Dhabi, United Arab Emirates, in the Middle East region.

How does Cleveland Clinic Abu Dhabi make money?

Four revenue lines are on record. Patient Care Services are the primary driver. The others are international Patient Services, executive Health Program and clinical Trials and Research.

Who are Cleveland Clinic Abu Dhabi's main competitors?

Direct peers on record are Saudi German Hospital Group, Mediclinic Middle East, NMC Healthcare, Healthpoint Abu Dhabi, King's College Hospital London (Dubai), Burjeel Hospital and American Hospital Dubai. Regional players are King Faisal Specialist Hospital and Research Centre and Sidra Medicine. Cleveland Clinic (US) is listed as a broad incumbent.

Does Cleveland Clinic Abu Dhabi have an API?

No public API is recorded for Cleveland Clinic Abu Dhabi.

What industry is Cleveland Clinic Abu Dhabi in?

Cleveland Clinic Abu Dhabi's product category is Multispecialty Hospital Services. Its primary akta.pro industry code is HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 62211 and its SIC code is 8062.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GulfNewsCleveland Clinic Abu Dhabi: Transforming heart health in the UAECleveland Clinic Abu Dhabi has expanded cardiac care with pioneering procedures and multidisciplinary expertise, including the UAE's first heart transplant in 2017 and over 50 transplants since. The hospital was designated a Centre of Excellence for Adult Cardiac Surgery in 2023 and ranked #1 in Cardiology in Newsweek's 2027 ranking.SciTechDailyA Tiny Wireless Device Could Transform How Chronic Pain Is TreatedResearchers at NYU Abu Dhabi and Cleveland Clinic Abu Dhabi developed a seed-sized injectable device that delivers wireless, battery-free electrical stimulation to nerves. The device can be placed via a standard needle and is designed to treat chronic pain and movement disorders with minimal invasiveness. The technology aims to complement existing therapies and expand access to advanced treatments.The NationalGastric stent developed in UAE could offer relief to patients after weight-loss surgeryResearchers at NYU Abu Dhabi, in collaboration with Cleveland Clinic Abu Dhabi, have developed a biodegradable 3D-printed gastric stent called Bridge to seal leaks that can occur after bariatric surgery. Unlike current bile-duct stents, it dissolves inside the body, avoiding a second operation for removal. The device requires further research before patient use.GulfNewsUAE Organ Transplants Reach 2,150 Lives Saved as Abu Dhabi Emerges Global Leader in Advanced Multi-Organ Transplant CareThe UAE has performed 2,150 organ transplants since the launch of the national 'Hayat' programme in 2017, with Abu Dhabi recording a 118% increase in procedures to 631 in 2025. This growth is attributed to an integrated ecosystem led by institutions such as Cleveland Clinic Abu Dhabi, SEHA, and Burjeel Medical City, supported by international partnerships for clinical excellence. The Department of Health – Abu Dhabi highlighted these achievements on World Organ Donation Day, emphasizing the role of advanced infrastructure and global collaborations in saving lives.The NationalNew implant for heart failure could halve hospital readmission ratesCleveland Clinic Abu Dhabi has implanted the CardioMEMS device in two patients to enable remote monitoring of pulmonary artery pressure, aiming to detect early signs of heart failure deterioration. The clinic reports that such remote monitoring can reduce hospital readmission rates by up to 57 percent by allowing doctors to intervene before symptoms manifest.YahooIntellistake Provides Scientific Overview of NanoAi's Nanotechnology Detection Process, Validated by One of the World's Leading Scientific PublishersIntellistake Technologies is providing a scientific overview of NanoAi Technologies' nanotechnology detection process in connection with its proposed C$17 million acquisition announced on August 4, 2026. The article highlights that NanoAi's core sensing technology was peer-reviewed and published in Scientific Reports, demonstrating high sensitivity and accuracy in clinical trials at Cleveland Clinic Abu Dhabi.Healthcare Asia MagazineCleveland Clinic Abu Dhabi rolls out Middle East’s first robot‑assisted bronchoscopyCleveland Clinic Abu Dhabi has launched the first robot-assisted bronchoscopy technology in the Middle East, allowing for more precise access to small lung nodules. The procedure, which is minimally invasive and lasts between 30 to 75 minutes, can aid in diagnosing various lung conditions, including cancer and infections. The clinic anticipates future applications for robotic surgical interventions related to cancer treatment.Digital Watch ObservatoryUAE accelerates healthcare transformation with robotic technologiesHealthcare providers in the United Arab Emirates are deploying robotic systems across surgery, blood collection, cardiac procedures, pharmacy, remote diagnostics, and rehabilitation services as part of a broader healthcare transformation effort. Cleveland Clinic Abu Dhabi uses the da Vinci robotic surgical platform for complex procedures, while Emirates Health Services has implemented AI-powered blood-drawing robots that can reduce patient waiting times by up to 50%. The expansion beyond surgical applications into routine clinical services signals the growing role of medical robotics in UAE healthcare, though questions remain about long-term impacts on costs and patient outcomes.The NationalAbu Dhabi introduces robot-assisted procedure to boost lung cancer detectionCleveland Clinic Abu Dhabi has become the first hospital in the Middle East to deploy the Monarch robotically-assisted bronchoscopy platform for lung cancer detection, developed by Johnson & Johnson MedTech. The technology uses 3D CT scan mapping to guide doctors to hard-to-reach lung nodules for biopsy in a minimally invasive 30-to-75-minute procedure, with clinical trials showing successful navigation to targeted nodules in 98.7 percent of cases. Abu Dhabi's Department of Health supported the rollout as part of the emirate's strategy to position itself as a regional reference centre for advanced medical technology.GulfNewsCleveland Clinic Abu Dhabi Unveils Middle East’s First Robotic Bronchoscopy, Transforming Early Lung Cancer DiagnosisCleveland Clinic Abu Dhabi has become the first hospital in the Middle East to introduce robotically assisted bronchoscopy using the MONARCH™ platform, enabling doctors to biopsy hard-to-reach lung nodules without open surgery. The minimally invasive procedure, performed under general anesthesia in 30 to 75 minutes, aims to improve early detection of Stage 1 lung cancer, which has a five-year survival rate exceeding 70%. The Department of Health – Abu Dhabi has supported the rollout as part of broader efforts to expand advanced medical technologies across the emirate.